1h Free Analyst Time
The publisher has been monitoring the ventricular drainage devices market and it is poised to grow by $ 284.64 mn during 2022-2026, accelerating at a CAGR of 8.92% during the forecast period. Our report on the ventricular drainage devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of brain surgeries, an increasing number of product launches, and an increasing number of M and As.
The ventricular drainage devices market analysis includes product segment and geographic landscape.
The publisher's ventricular drainage devices market is segmented as below:
By Product
- Ventricular drainage accessories
- Ventricular drainage systems
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing neurology specialty hospitals and clinics as one of the prime reasons driving the ventricular drainage devices market growth during the next few years. Also, technological advancements to improve ventricular drainage and growing adoption of robot assisted neurosurgery will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on ventricular drainage devices market covers the following areas:
- Ventricular drainage devices market sizing
- Ventricular drainage devices market forecast
- Ventricular drainage devices market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ventricular drainage devices market vendors that include Acandis GmbH, B. Braun SE, BIOMEDICA ITALIA S.R.L., Calon Cardio Technology Ltd., Delta, Desu Medical, Fuji Systems Co. Ltd., Integra Lifesciences Holdings Corp., IRRAS AB, LivaNova Plc, Medtronic Plc, Moller Medical GmbH, Natus Medical Inc., Neuromedex GmbH, Salvavidas Pharmaceutical Pvt. Ltd., Silmag, Sophysa, Spiegelberg GmbH and Co. KG, Wellona Pharma, and Yushin Medical Co. Ltd.. Also, the ventricular drainage devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Exhibits:
Executive Summary
The publisher recognizes the following companies as the key players in the global ventricular drainage devices market: Acandis GmbH, B. Braun SE, BIOMEDICA ITALIA S.R.L., Calon Cardio Technology Ltd., Delta, Desu Medical, Fuji Systems Co. Ltd., Integra Lifesciences Holdings Corp., IRRAS AB, LivaNova Plc, Medtronic Plc, Moller Medical GmbH, Natus Medical Inc., Neuromedex GmbH, Salvavidas Pharmaceutical Pvt. Ltd., Silmag, Sophysa, Spiegelberg GmbH and Co. KG, Wellona Pharma, and Yushin Medical Co. Ltd.Commenting on the report, an analyst from the publisher said: "The latest trend gaining momentum in the market is growing neurology specialty hospitals and clinics."
According to the report, one of the major drivers for this market is the increasing prevalence of brain surgeries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acandis GmbH
- B. Braun Se
- Biomedica Italia S.R.L.
- Calon Cardio Technology Ltd.
- Delta
- Desu Medical
- Fuji Systems Co. Ltd.
- Integra Lifesciences Holdings Corp.
- Irras Ab
- Livanova plc
- Medtronic plc
- Moller Medical GmbH
- Natus Medical Inc.
- Neuromedex GmbH
- Salvavidas Pharmaceutical Pvt. Ltd.
- Silmag
- Sophysa
- Spiegelberg GmbH and Co. Kg
- Wellona Pharma
- Yushin Medical Co. Ltd.
